Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TCT Conference In Brief

This article was originally published in The Gray Sheet

Executive Summary

Clinical data news from the Transcatheter Cardiovascular Therapeutics conference held last week in Miami.

You may also be interested in...



SCAI Produces Consensus On Intra-Coronary Diagnostic Tools

A group of experts convened by the Society for Cardiovascular Angiography and Interventions has produced recommendations for the optimal clinical application of three underutilized intra-coronary diagnostics – fractional flow reserve, intravascular ultrasound and optical coherence tomography – to improve patient care, especially in patients with complex heart disease or coronary lesions difficult to assess with standard angiography.

New Products In Brief

Abbott earns approval in Japan for Xience Xpedition everolimus-eluting stent. Zimmer will distribute SpineCraft’s APEX system. More new product news.

Direct Flow Medical Secures CE Mark For TAVR Device

Direct Flow Medical announced Jan. 28 the receipt of a CE mark for its transcatheter aortic heart valve system, to compete with Edwards, Medtronic among others in burgeoning market.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT031695

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel